Drug susceptibility profiling of tuberculous meningitis

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 1, 2008, Pages 105-107

  Nagarathna, S ^a   Rafi, W ^a   Veenakumari, H B ^a   Mani, R ^a   Satishchandra, P ^a   Chandramuki, A ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Cerebrospinal fluid; Multidrug resistance; Tuberculous meningitis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; ISOLATION PROCEDURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUBERCULOUS MENINGITIS;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ETHAMBUTOL; HUMANS; INFANT; ISONIAZID; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; RIFAMPIN; STREPTOMYCIN; TUBERCULOSIS, MENINGEAL; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 38349046658     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. World Health Organization. WHO report on the tuberculosis epidemic. WHO/TB/97.223. Geneva, Switzerland: WHO, 1997.
2. Association of Physicians of India (API) Consensus Expert Committee. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. J Assoc Physicians India 2006; 54: 219-234.
3. Udwadia Z F. India's multi-drug resistant tuberculosis crisis. Ann N Y Acad Sci 2001; 953: 98-105.
4. Paramasivan C N, Venkataraman P, Chandrasekaran V, Bhat S, Narayanan P R. Surveillance of drug resistance in tuberculosis in two districts of South India. Int J Tuberc Lung Dis 2002; 6: 479-484.
5. Zignol M, Hosseini M S, Wright A, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006; 194: 479-485.
6. Girgis N I, Sultan Y, Farid Z, et al. Tuberculosis meningitis. Abbassia Fever Hospital, Naval Medical Research Unit No. 3, Cairo, Egypt, from 1976 to 1996. Am J Trop Med Hyg 1998; 58: 28-34.
7. Patel V B, Padayatchi N, Bhigjee A I, et al. Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa. Clin Infect Dis 2004; 38: 851-856.
8. Thwaites G E, Lan N T, Dung N H, et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 2005; 192: 79-88.
9. Ellard G A, Humphries M J, Allen B W. Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis. Am Rev Respir Dis 1993; 148: 650-655.
10. Daikos G L, Cleary T, Rodriguez A, Fischl M A. Multidrug-resistant tuberculous meningitis in patients with AIDS. Int J Tuberc Lung Dis 2003; 7: 394-398.